CoChat

Therapeutic role of long non-coding RNA TCONS_00019174 in depressive disorders is dependent on Wnt/β-catenin signaling pathway

Open access
Ni, Xinqiang, Liao, Yingzhao, Li, Limin, Zhang, Xiaoli, Wu, Zhengzhi · 2018 · Journal of Integrative Neuroscience
Cited by 37

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Chronic stress is one of the major causes that lead to major depressive disorder, which is a prevalent mood disorder worldwide. Many patients with major depressive disorder do not benefit from available medication due to the complex etiology of the condition. Recently, long non-coding RNAs, molecular switches of downstream genes expression, have been reported to be involved in the pathogenesis of major depressive disorder. The long non-coding RNA TCONS_00019174 has been implicated in major depressive disorder risk and antidepressant effects, However, the effect of long non-coding RNA TCONS_00019174 on antidepressant responses has not been investigated. This study is designed to determine whether altered expression of long non-coding RNA TCONS_00019174 contributes to depression-like behaviors associated with chronic stress. We found that mice exposed to chronic ultra-mild stress displayed apparent depression-like behaviors and decreased expression of long non-coding RNA TCONS_00019174 in hippocampus. Both changed behaviors and long non-coding RNA TCONS_00019174 expression level were rescued by chronic treatment with imipramine. Viral-mediated long non-coding RNA TCONS_00019174 overexpression in hippocampal neurons improved the behaviors of mice exposed to chronic ultra-mild stress. Further, it was found long non-coding RNA TCONS_00019174 overexpression upregulated phosphorylated-GSK3$\beta$(p-GSK3$\beta$) protein and $\beta$-catenin in the hippocampus. These findings suggest that long non-coding RNA TCONS_00019174 exerts antidepressant-like effect in mice by activating a Wnt/$\beta$-catenin pathway, and that long non-coding RNA may serve as a potential therapeutic target for major depressive disorder in clinical application.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31083/jin-170052

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. Krishnan V, Nestler EJ ( 2008) The molecular neurobiology of depression. Nature 455(7215), 894-902. · DOI · Paper page
  2. Franklin TB, Saab BJ, Mansuy IM ( 2012) Neural mechanisms of stress resilience and vulnerability. Neuron 75(5), 747-761. · DOI · Paper page
  3. Im HI, Kenny PJ ( 2012) MicroRNAs in neuronal function and dysfunction. Trends in Neurosciences 35(5), 325-334. · DOI · Paper page
  4. Schmidt HD, Shelton RC, Duman RS ( 2011) Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 36(12), 2375-2394. · DOI · Paper page
  5. Oquendo MA, McGrath P, Weissman MM ( 2014) Biomarker studies and the future of personalized treatment for depression. Depression and Anxiety 31(11), 902-905. · DOI
  6. Bartel DP ( 2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2), 215-233. · DOI · Paper page
  7. Kosik KS ( 2006) The neuronal microRNA system. Nature Reviews Neuroscience 7(12), 911-920. · DOI · Paper page
  8. Geaghan M, Cairns MJ ( 2015) MicroRNA and posttranscriptional dysregulation in psychiatry. Biological Psychiatry 78(4), 231-239. · DOI · Paper page
  9. Kocerha J, Dwivedi Y, Brennand KJ ( 2015) Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease. Molecular Psychiatry 20(6), 677-684. · DOI · Paper page
  10. O'connor R, Dinan T, Cryan J ( 2012) Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression. Molecular Psychiatry 17(4), 359-376. · DOI
  11. Ponjavic J, Oliver PL, Lunter G, Ponting CP ( 2009) Genomic and transcriptional co-localization of protein-coding and long non-coding RNA pairs in the developing brain. PLos Genetics 5(8), e1000617. · DOI · Paper page
  12. Yang F, Zhang L, Huo XS, Yuan Jh, Xu D, Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ ( 2011) Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 54(5), 1679-1689. · DOI · Paper page
  13. Cui X, Sun X, Niu W, Kong L, He M, Zhong A, Chen S, Jiang K, Zhang L, Cheng Z ( 2016) Long non-coding RNA: Potential diagnostic and therapeutic biomarker for major depressive disorder. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 22, 5240-5248. · DOI · Paper page
  14. Voleti B, Duman R ( 2012) The roles of neurotrophic factor and Wntsignaling in depression. Clinical Pharmacology & Therapeutics 91(2), 333-338. · DOI · Paper page
  15. Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H ( 2004) Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on b-catenin in mouse hippocampus. Biological Psychiatry 55(8), 781-784. · DOI · Paper page
  16. Uchida S, Hara K, Kobayashi A, Otsuki K, Yamagata H, Hobara T, Suzuki T, Miyata N, Watanabe Y ( 2011) Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 69(2), 359-372. · DOI · Paper page
  17. Uchida S, Hara K, Kobayashi A, Fujimoto M, Otsuki K, Yamagata H, Hobara T, Abe N, Higuchi F, Shibata T ( 2011) Impaired hippocampal spinogenesis and neurogenesis and altered affective behavior in mice lacking heat shock factor 1. Proceedings of the National Academy of Sciences of the United States of America 108(4), 1681-1684. · DOI · Paper page
  18. Seibenhener ML Wooten MW, ( 2012) Isolation and culture of hippocampal neurons from prenatal mice. Journal of Visualized Experiments 65(65), e3634 . · doi:10.3791/3634-v · Paper page
  19. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP ( 2009) Neurogenesisdependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62(4), 479-493. · DOI · Paper page
  20. Porsolt R, Bertin A, Jalfre M ( 1977) Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 229(2), 327-336.
  21. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O ( 2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301(5634), 805-809. · DOI · Paper page
  22. Kuss AW, Chen W ( 2008) MicroRNAs in brain function and disease. Current Neurology and Neuroscience Reports 8(3), 190-197. · DOI · Paper page
  23. Song MF, Dong JZ, Wang YW, He J, Ju X, Zhang L, Zhang YH, Shi JF, Lv YY ( 2015) CSF miR-16 is decreased in major depression patients and its neutralization in rats induces depression-like behaviors via a serotonin transmitter system. Journal of Affective Disorders 178, 25-31. · DOI
  24. Fan HM, Sun XY, Guo W, Zhong AF, Niu W, Zhao L, Dai YH, Guo ZM, Zhang LY, Lu J ( 2014) Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients. Journal of Psychiatric Research 59, 45-52. · DOI
  25. Song HT, Sun XY, Zhang L, Zhao L, Guo ZM, Fan HM, Zhong AF, Niu W, Dai YH, Zhang LY ( 2014) A preliminary analysis of association between the down-regulation of microRNA-181b expression and symptomatology improvement in schizophrenia patients before and after antipsychotic treatment. Journal of Psychiatric Research 54, 134-140. · DOI
  26. Sun XY, Lu J, Zhang L, Song HT, Zhao L, Fan HM, Zhong AF, Niu W, Guo ZM, Dai YH ( 2015) Aberrant microRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients. Journal of Clinical Neuroscience 22(3), 570-574. · DOI
  27. Jope RS, Roh MS ( 2006) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Current Drug Targets 7(11), 1421-1434. · DOI · Paper page
  28. Ge JF, Peng YY, Qi CC, Chen FH, Zhou JN ( 2014) Depression-like behavior in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization. Endocrine 45( 3), 430-438. · DOI
  29. Yu X, Malenka RC ( 2003) b-catenin is critical for dendritic morphogenesis. Nature Neuroscience 6(11), 1169-1177. · DOI · Paper page
  30. Karege F, Perroud N, Burkhardt S, Fernandez R, Ballmann E, La Harpe R, Malafosse A ( 2012) Protein levels ofβ-catenin and activation state of glycogen synthase kinase-3β in major depression. A study with postmortem prefrontal cortex. Journal of Affective Disorders 136(1, 2), 185-188. · DOI
  31. Pilar-CuÉllar F, Vidal R, Pazos A ( 2012) Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, b-catenin and antidepressant-like effects. British Journal of Pharmacology 165(4b), 1046-1057. · DOI · Paper page

Cited by

See all 37

Metadata

Authors
Ni, X., Liao, Y., Li, L., Zhang, X., & Wu, Z.
Venue
Journal of Integrative Neuroscience
Publisher
IMR Press
Published
2018-05-15
Volume
17
Issue
2
Pages
125-132
ISSN
  • 0219-6352 (ISSN-L)
  • 1757-448X
OpenAlex
W2761510811
Cited by
37
References
12
FWCI
3.11
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.